NCT07626749

Brief Summary

This study examines whether simple speech tasks and a swallowing screening test can help identify swallowing risk in adults of different ages. Participants will complete basic questions, a swallowing self-assessment, a saliva swallowing test, and short voice recordings of rapid syllables. The study is non-invasive, takes about 75 minutes, and may help develop an easy, low-cost screening tool for early swallowing problems.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
720

participants targeted

Target at P75+ for all trials

Timeline
46mo left

Started Jun 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 4, 2026

Completed
11 days until next milestone

Study Start

First participant enrolled

June 15, 2026

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2030

Last Updated

June 4, 2026

Status Verified

May 1, 2026

Enrollment Period

3.8 years

First QC Date

May 22, 2026

Last Update Submit

May 29, 2026

Conditions

Keywords

DysphagiaSwallowing FunctiondiadochokineticAcoustic AnalysisRepetitive Saliva Swallowing TestEAT-10Older Adults

Outcome Measures

Primary Outcomes (1)

  • Repetitive Saliva Swallowing Test Classification

    Classification of swallowing function based on the Repetitive Saliva Swallowing Test (RSST). Participants will be classified as having normal RSST performance if they complete greater than or equal to 3 swallows in 30 seconds, and abnormal RSST performance if they complete fewer than 3 swallows in 30 seconds.

    Day 1

Secondary Outcomes (10)

  • Eating Assessment Tool-10 Total Score

    Day 1

  • Diadochokinetic Speech Rate

    Day 1

  • Diadochokinetic Speech Fundamental Frequency

    Day 1

  • Diadochokinetic Speech First Formant Frequency

    Day 1

  • Diadochokinetic Speech Second Formant Frequency

    Day 1

  • +5 more secondary outcomes

Other Outcomes (8)

  • Participant Age

    Day 1

  • Participant Sex

    Day 1

  • Education Level

    Day 1

  • +5 more other outcomes

Study Arms (1)

Age-Based Cohort

Community-dwelling adults aged 18 years and older who complete a single study visit including demographic questionnaire, EAT-10, RSST, and DDK speech recordings. This is an observational cohort with no intervention, and data will be analyzed by age group.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of community-dwelling adults aged 18 years and older, with no upper age limit, who are able to communicate in Mandarin or Taiwanese, provide informed consent, and complete DDK tasks, RSST, and EAT-10 assessment. Participants will be recruited from community organizations and related settings in the Kaohsiung-Pingtung region. The study uses a single-visit observational design with age-based subgroup analyses and no intervention.

You may qualify if:

  • Community-dwelling adults aged 18 years or older, with no upper age limit.
  • Ability to communicate in Mandarin or Taiwanese and understand the study procedures.
  • Willingness to provide written informed consent.
  • Ability to complete the DDK tasks and RSST.

You may not qualify if:

  • Presence of acute respiratory infection, upper respiratory inflammation, or other acute conditions that may significantly affect speech or swallowing.
  • Impaired consciousness, significant cognitive deficits, or inability to understand the study procedures.
  • Recent surgery or radiotherapy involving the oral cavity or pharynx that affects speech or swallowing.
  • Severe hearing impairment that prevents understanding of instructions.
  • Any other condition deemed unsuitable for participation by the investigators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Sports Medicine, Kaohsiung Medical University, Taiwan

Kaohsiung City, Taiwan, 807, Taiwan

Location

MeSH Terms

Conditions

Deglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • GUO L Y Professor and Dean of the College of Health Sciences, Departme, Ph. D.

    Department of Sports Science, Kaohsiung Medical University, Taiwan

    STUDY CHAIR

Central Study Contacts

HUNG C F Kaohsiung Medical University, MASTER

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 22, 2026

First Posted

June 4, 2026

Study Start

June 15, 2026

Primary Completion (Estimated)

April 9, 2030

Study Completion (Estimated)

April 9, 2030

Last Updated

June 4, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data collected during the trial, including baseline characteristics, intervention-related measures, and outcome data, will be shared with a data dictionary.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
De-identified individual participant data (IPD) and supporting information will be available starting 2 years after publication of the primary study results and will remain accessible for 5 years.
Access Criteria
De-identified individual participant data and related supporting documents will be made available only to qualified researchers affiliated with academic institutions, medical organizations, or public health agencies. Requesters must submit a detailed research proposal and evidence of ethical approval. Access will be granted subject to approval by the study team.

Locations